Serum pepsinogen levels and their influencing factors:A population-based study in 6990 Chinese from North China

被引:41
作者
Li-Ping Sun
机构
关键词
Pepsinogen; Gastric cancer; Helicobacter pylori; Screening;
D O I
暂无
中图分类号
R573 [胃疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM: To explore the essential characteristics of serum pepsinogen (PG) levels in Chinese people, by analyzing the population-based data on the serum levels of PG Ⅰ and Ⅱ and the PGⅠ/Ⅱ ratio, and their influencing factors in Chinese from North China. METHODS: A total of 6990 subjects, who underwent a gastric cancer screening in North China from 1997 to 2002, were collected in this study. Serum pepsinogen levels were measured by enzyme-linked immunosorbent assay (ELISA). H pylori status was determined by histological examination and H pylori-IgG ELISA. The cut-off point was calculated by using receiving operator characteristics (ROC) curves. Factors linked to serum PG Ⅰ/Ⅱ ratio were identified using a multivariate logistic regression. RESULTS: The serum PGⅠ and PGⅡ levels were significantly higher in males than in females (95.2 μg/L vs 79.7 μg/L, P < 0.01; 12.1 μg/L vs 9.4 μg/L, P < 0.01), PGⅠ/Ⅱ ratio was significantly lower in males than in females (7.9 vs 8.3, P < 0.01). The PG Ⅰ/Ⅱ ratio decreased significantly in the aged groups following the progression of gastric mucosa from normal to non-atrophic and atrophic lesions (10.4, 8.8, and 6.6, respectively). The serum PGⅠand Ⅱ levels were significantly higher in patients with H pylori infection than in those without H pylori infection (88.7 μg/L vs 81.4 μg/L, P < 0.01; 11.4 μg/L vs 8.4 μg/L, P < 0.01), while the PGⅠ/Ⅱ ratio was significantly lower in patients with H pylori infection than in those without H pylori infection (7.7 vs 9.6, P < 0.01). For patients with atrophic lesions, the area under the PGⅠ/Ⅱ ROC curve was 0.622. The best cut-off point for PGⅠ/Ⅱ was 6.9, with a sensitivity of 53.2%, and a specificity of 67.5%. Factors linked to PGⅠ/Ⅱ were sensitive to identified PG using a multinomial logistic regression relying on the following inputs: males (OR: 1.151, 95% CI: 1.042-1.272, P = 0.006), age ≥ 61 years (OR: 1.358, 95% CI: 1.188-1.553, P = 0.000), atrophic lesion (OR: 2.075, 95% CI: 1.870-2.302, P = 0.000), and H pylori infection (OR: 1.546, 95% CI: 1.368-1.748, P = 0.000). CONCLUSION: The essential characteristics of serum PG levels in Chinese are significantly skewed from the normal distribution, and influenced by age, sex, gastric mucosa lesions and H pylori infection. PGⅠ/Ⅱ ratio is more suitable for identifying subgroups with different influence factors compared with PGⅠor PGⅡ alone.
引用
收藏
页码:6562 / 6567
页数:6
相关论文
共 14 条
[1]   胃癌高发区农村居民血清胃蛋白酶原和胃泌素分析 [J].
张祥宏 ;
赵文元 ;
孙旭明 ;
卜玉华 ;
严霞 ;
王俊灵 ;
王会艳 ;
张振国 ;
米建民 ;
谢同欣 ;
三角顺一 ;
青木一雄 ;
王凤荣 .
中国公共卫生, 2002, (03) :35-36
[2]   Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies [J].
Checchi, Serenella ;
Montanaro, Annalisa ;
Pasqui, Letizia ;
Ciuoli, Cristina ;
Cevenini, Gabriele ;
Sestini, Fausta ;
Fioravanti, Carla ;
Pacini, Furio .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (11) :4346-4351
[3]   Gastric cancer screening using the serum pepsinogen test method [J].
Miki K. .
Gastric Cancer, 2006, 9 (4) :245-253
[4]   The translation of Helicobacter pylori basic research to patient care [J].
Ernst, PB ;
Peura, DA ;
Crowe, SE .
GASTROENTEROLOGY, 2006, 130 (01) :188-206
[5]  
Normal serum pepsinogen I levels in adults: A population‐based study with special reference to Helicobacter pylori infection and parietal cell antibodies[J] . S. Hokkanen,T. U. Kosunen,S. Sarna,A. Miettinen,A. Salomaa,A. Aromaa,P. Knekt,H. I. Rautelin.Scandinavian Journal of Clinical & Laboratory Investigation . 2005 (4)
[6]  
Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening[J] . Journal of Medical Screening . 2004 (3)
[7]  
Improvement in serum pepsinogens and gastrin in long‐term monitoring after eradication of Helicobacter pylori: comparison with H. pylori‐negative patients[J] . T.Ohkusa,H.Miwa,T.Nomura,D.Asaoka,A.Kurosawa,N.Sakamoto,S.Abe,M.Hojo,T.Terai,T.Ogihara,N.Sato.Alimentary Pharmacology & Therapeutics . 2004
[8]   Usefulness of gastric cancer screening using the serum pepsinogen test method [J].
Miki, K ;
Morita, M ;
Sasajima, M ;
Hoshina, R ;
Kanda, E ;
Urita, Y .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (04) :735-739
[9]   Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection [J].
Di Mario, F ;
Moussa, AM ;
Caruana, P ;
Merli, R ;
Cavallaro, LG ;
Cavestro, GM ;
Dal Bò, N ;
Iori, V ;
Pilotto, A ;
Leandro, G ;
Franzè, A ;
Rugge, M .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (12) :1223-1227
[10]  
Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development[J] . T. Kageyama.Cellular and Molecular Life Sciences . 2002 (2)